Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
Top Cited Papers
- 1 July 2007
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (7) , 910-915
- https://doi.org/10.1136/ard.2006.066415
Abstract
Background: Structural changes such as erosions, syndesmophytes and ankylosis are characteristic of ankylosing spondylitis (AS). These can be quantified by the modified Stokes Anklylosing Spondylitis Spinal Score (mSASSS). It is unknown which radiographic feature is most relevant for the assessment of change and the prediction of future damage in AS. Objectives: To analyse radiographic progression in AS by using different assessments to define the most important changes. Methods: Spinal radiographs of 116 patients with AS were scored by the mSASSS at baseline (BL) and after 2 years. Radiographic progression was assessed by differentiating (1) any change; (2) progression to syndesmophytes/ankylosis (definite change); and (3) changes exceeding the smallest detectable change (SDC) as predefined. A growth angle of 45° was used to differentiate syndesmophytes from spondylophytes. Results: Some radiographic progression after 2 years was detected in 42% of patients, novel syndesmophytes in 31% of patients, and, using the SDC (calculated at 2 mSASSS units) as cut-off, progression was seen in 28% of patients. Thus, in 74% of the patients changes were because of syndesmophytes and/or ankylosis. Using the predefined cut-off, only 12% of all syndesmophytes were spondylophytes. Patients with such changes were of older age. Definite radiographic progression was found in 44% of the patients with syndesmophytes/ankylosis at BL (n = 57) versus 19% (p = 0.03) of the patients without such changes (n = 59). Conclusions: Syndesmophytes and ankylosis are the most relevant structural changes in AS, and also in the mSASSS. Development of just one syndesmophyte within 2 years indicates progression of structural changes in AS; this is relevant for clinical practice. Syndesmophytes are the best predictors of radiographic progression.Keywords
This publication has 27 references indexed in Scilit:
- The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 yearAnnals of the Rheumatic Diseases, 2006
- Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back painAnnals of the Rheumatic Diseases, 2006
- Therapy of ankylosing spondylitis – a review. Part I: Conventional medical treatment and surgical therapyScandinavian Journal of Rheumatology, 2005
- Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or changeAnnals of the Rheumatic Diseases, 2005
- Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateArthritis & Rheumatism, 2004
- Radiographic progression depicted by probability plots: Presenting data with optimal use of individual valuesArthritis & Rheumatism, 2004
- How to report radiographic data in randomized clinical trials in rheumatoid arthritis: Guidelines from a roundtable discussionArthritis Care & Research, 2002
- Assessing Smallest Detectable Change Over Time in Continuous Structural Outcome Measures: Application to Radiological Change in Knee OsteoarthritisJournal of Clinical Epidemiology, 1999
- The sacroiliac joint in the spondyloarthropathiesCurrent Opinion in Rheumatology, 1996
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984